Allenex (investor - Corporate Investor)

See something wrong or missing? Let us know
Offices:Stockholm

Allenex is a life science company in Sweden

Average round investment:12.21M USD
Average number per year:1.0
Distribution: 2026 (1)
Portfolio companies: Sweden Verigraft
Mostly invests in: Sweden Sweden (1) Health services (1)

1 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Allenex

Name Criteria
Sweden Bengt Julander
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Linc Invest
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Riyadh Valley Company
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
3B Ventures
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Fredrik Ljungström
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Sweden Ann-Helene Ljungström
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Amboy Street Ventures
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
United States Balaji Srinivasan
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 3.8
  • Active last 12 months: Yes
Netherlands Catalyze Capital
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United Kingdom Manta Ray
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Top